Učitavanje...
Effects on LOS may not justify cost of remdesivir for severe COVID-19
Spremljeno u:
| Izdano u: | PharmacoEcon Outcomes News |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7790512/ https://ncbi.nlm.nih.gov/pubmed/33437147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40274-021-7380-1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|